1-19 of 19
Benedicte Hivert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Final Results of the Eradic Trial from the Filo Group

Anne Sophie Michallet, Remi Letestu, Magali Legarff, Stéphane Morisset, Therese Aurran-Schleinitz, Kamel Laribi, Vincent Levy, Laurence Simon, Damien Roos Weil, Marie Sarah Dilhuydy, Cecile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie De Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Lepretre, Philippe Carassou, Julie Gay, Benedicte Hivert, Luc-Matthieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Omar Benbrahim, Xavier Cahu, Florence Nguyen Khac, Valerie Rouillé, Loic Ysebaert, Anne Quinquenel
Journal: Blood
Blood (2024) 144 (Supplement 1): 584.
https://doi.org/10.1182/blood-2024-194593
Published: 2024
Journal Articles

Combination of CD20xCD3 Bispecific Antibodies with Ibrutinib and Lenalidomide Shows Efficacy in Relapsed/ Refractory CNS Lymphoma

Sandy Amorim, Benjamin Carpentier, Emmanuelle Bourgeois Petit, Benedicte Hivert, Vincent Thibaud, Alexandre Willaume, Laurent Pascal
Journal: Blood
Blood (2024) 144 (Supplement 1): 6453.
https://doi.org/10.1182/blood-2024-200197
Published: 2024
Journal Articles

Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group

Anne-Sophie Michallet, Anne Quinquenel, Remi Letestu, Tavernier Magali, Stéphane Morisset, Therese Aurran, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos Weil, Veronique Leblond, Marie Sarah Dilhuydy, Cecile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie De Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Lepretre, Philippe Carassou, Julie Gay, Benedicte Hivert, Luc Matthieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen Khac, Valerie Rouillé, Alain Jacques Delmer
Journal: Blood
Blood (2023) 142 (Supplement 1): 3268.
https://doi.org/10.1182/blood-2023-173341
Published: 2023
Journal Articles

Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype

Alexandre Willaume, Mourtaza Karimdjee, Sandy Amorim, Benjamin Carpentier, Benedicte Hivert, Emmanuelle Bourgeois-Petit, Pierre Gosset, Alban Bailliez, Laurent Pascal
Journal: Blood
Blood (2022) 140 (Supplement 1): 3835–3836.
https://doi.org/10.1182/blood-2022-159375
Published: 2022
Journal Articles

Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation

Anne Quinquenel, Rémi Letestu, Magali Le Garff-Tavernier, Fabien Subtil, Therese Aurran-Schleinitz, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos-Weil, Véronique Leblond, Marie-Sarah Dilhuydy, Caroline Dartigeas, Cecile Tomowiak, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie de Guibert, Pierre Feugier, Fatiha Merabet, Stephane Lepretre, Philippe Carassou, Julie Gay, Bénédicte Hivert, Luc Mathieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen Khac, Valérie Rouille, Alain Delmer, Anne-Sophie Michallet
Journal: Blood
Blood (2022) 140 (Supplement 1): 7007–7009.
https://doi.org/10.1182/blood-2022-159678
Published: 2022
Journal Articles

Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group

Romain Guieze, Loic Ysebaert, Damien Roos-Weil, Luc-Matthieu Fornecker, Emmanuelle Ferrant, Lysiane Molina, Thérèse Aurran-Schleinitz, Aline Clavert, Sophie de Guibert, Anne-Sophie Michallet, Alain Saad, Bernard Drenou, Philippe Quittet, Benedicte Hivert, Kamel Laribi, Julie Gay, Julien Broséus, Valérie Rouille, David Schwartz, Bruno Pereira, Alain Delmer, Pierre Feugier
Journal: Blood
Blood (2022) 140 (Supplement 1): 6631–6632.
https://doi.org/10.1182/blood-2022-159695
Published: 2022
Journal Articles

Blinatumomab for Patients with Richter's Syndrome: A Multicenter Phase 2 Trial from the Filo Group

Romain Guieze, Loic Ysebaert, Damien Roos-Weil, Lysiane Molina, Luc Mathieu Fornecker, Thérèse Aurran, Anne-Sophie Michallet, Emmanuelle Ferrant, Aline Clavert, Alain Saad, Sophie de Guibert, Bernard Drenou, Philippe Quittet, Bénédicte Hivert, Kamel Laribi, Julie Gay, Julien Broséus, Valérie Rouille, David Schwartz, Bruno Pereira, Alain Delmer, Pierre Feugier
Journal: Blood
Blood (2021) 138 (Supplement 1): 3570.
https://doi.org/10.1182/blood-2021-147467
Published: 2021
Journal Articles

Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR

Anne-Sophie Michallet, Anne Quinquenel, Remi Letestu, Magali Le Garff-Tavernier, Fabien Subtil, Mad-Helenie Elsensohn, Therese Aurran, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos-Weil, Veronique Leblond, Marie-Sarah Dilhuydy, Cécile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie de Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Leprêtre, Philippe Carassou, Julie Gay, Bénédicte Hivert, Luc Mathieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen-Khac, Valérie Rouille, Alain Delmer
Journal: Blood
Blood (2021) 138 (Supplement 1): 641.
https://doi.org/10.1182/blood-2021-145624
Published: 2021
Journal Articles

High Frequency of CNS Involvement in Transformed Waldenström Macroglobulinemia

Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Elise Toussaint, Efstathios Kastritis, Shirley D'Sa, Miguel Alcoceba, Cécile Tomowiak, Bénédicte Hivert, Caroline Protin, Jithma P. Abeykoon, Josephine M.I. Vos, Anne-Sophie Michallet, Cyrielle Rodier, Jehan Dupuis, Stéphane Leprêtre, Fatiha Merabet, Xavier Roussel, Jean-Marc Zini, Caroline Regny, Aisha S Patel, Pierre Morel, Damien Roos-Weil, Steven P. Treon, Meletios A. Dimopoulos, Ramon Garcia-Sanz, Prashant Kapoor, Jorge J. Castillo, Alain Delmer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2526.
https://doi.org/10.1182/blood-2021-145440
Published: 2021
Journal Articles

Blinatumomab after R-CHOP Debulking Therapy for Patients with Richter Transformation: Preliminary Results of the Multicenter Phase 2 Blinart Trial from the Filo Group

Romain Guieze, MD, Loic Ysebaert, MD PhD, Lysiane Molina, MD, Damien Roos-Weil, MDPhD, Anne-Sophie Michallet, MD PhD, Benedicte Hivert, MD, Julie Gay, MD, Alain Saad, MD, Luc Mathieu Fornecker, MD PhD, Julien Broséus, Valérie Rouille, Laëtitia Auvray, Alain Jacques Delmer, MD PhD, Pierre Feugier, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-136667
Published: 2020
Journal Articles

Bortezomib in Combination with Dexamethasone, Rituximab and Cyclophosphamide (B-DRC) As First - Line Treatment of Waldenstrom's Macroglobulinemia: Results of a Prospectively Randomized Multicenter European Phase II Trial

Christian Buske, MD, Meletios A Dimopoulos, Alexander Grunenberg, MD, Efstathios Kastritis, MD, Cecile Tomowiak, MD, Béatrice Mahé, MD, Xavier Troussard, MD, Roman Hajek, MD PhD, Andreas Viardot, Professor Dr, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, MD, Hacene Zerazhi, MD, Benedicte Hivert, MD, Veronique Leblond, MD PhD, Sophie de Guibert, MD, Lena Brandefors, Ramon Garcia-Sanz, Maria Gomes da Silva, MD, Eva Kimby, MD PhD, Jens Dreyhaupt, Rainer Muche, Pierre Morel, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-140933
Published: 2020
Journal Articles

Outcome of Patients Receiving Venetoclax for Chronic Lymphocytic Leukemia (CLL) in Real-Life Clinical Practice: Results of the French ATU Program on Behalf of the Filo Group

Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, MD, Sandy Amorim, MD, Florence Cymbalista, MD PhD, Charles Herbaux, MD, Sophie de Guibert, MD, Damien Roos-Weil, MD, Benedicte Hivert, MD, Thérèse Aurran, MD, Jehan Dupuis, MD, Anaise Blouet, MD, Emmanuelle Tchernonog, MD, Kamel Laribi, MD, Natalia Dmytruk, MD, Pierre Morel, Anne-Sophie Michallet, MD PhD, Caroline Dartigeas, MD, Laure Farnault, MD, Anne Lavaud, MD, Isabelle Plantier, MD, Jacques-Olivier Bay, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Pierre Feugier, Loic Ysebaert, MD PhD, Romain Guieze, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5549.
https://doi.org/10.1182/blood-2018-99-118622
Published: 2018
Journal Articles

Safety Profile of Bortezomib Impacts Survival in Light Chain Amyloidosis

Zoé Van de Wyngaert, MD, Greg Vanoutryve, Guillemette Fouquet, MD, Stéphanie Guidez, Charles Herbaux, MD, Helene Demarquette, MD, Loic Renaud, Louis Terriou, MD, Marie Pierre Noel, MD, Marie Odile Petillon, MD, Bénédicte Hivert, MD, Matthieu Wemeau, MD, David Launay, MDPhD, Nicolas Lamblin, MD, Eric Hachulla, MD PhD, Thierry Facon, MD, Xavier Leleu, MD
Journal: Blood
Blood (2014) 124 (21): 5664.
https://doi.org/10.1182/blood.V124.21.5664.5664
Published: 2014
Journal Articles

Prognostic Of IgD Myeloma In The Era Of Novel Agents

Luca Inchiappa, MD, Charles Herbaux, MD, Stéphanie Guidez, MD, Guillemette Fouquet, MD, David Beauvais, MD, Zoé Van de Wyngaert, MD, Helene Demarquette, MD, Sarah Bonnet, MD, Bénédicte Hivert, MD, Mathieu Wemeau, MD, Nathalie Cambier, MD, Christian Rose, MD, Maxime Bemba, MD, Jean Michel Pignon, MD, Thierry Facon, MD, Bruno Royer, MD, Murielle Roussel, MD, Denis Caillot, MD, Marc Wetterwald, MD, PhD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1880.
https://doi.org/10.1182/blood.V122.21.1880.1880
Published: 2013
Journal Articles

Impact Of Initial FGD-PET CT and Serum Free Light Chain On Transformation Of Solitary Plasmacytoma To MM

Guillemette Fouquet, MD, Stéphanie Guidez, MD, Charles Herbaux, MD, Zoé Van de Wyngaert, MD, Sarah Bonnet, MD, David Beauvais, MD, Helene Demarquette, MD, Bénédicte Hivert, MD, Mathieu Wemeau, MD, Louis Terriou, MD, Valérie Coiteux, Margaret Macro, MD, Olivier Decaux, MD, Thierry Facon, MD, Damien Huglo, MD, PhD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1888.
https://doi.org/10.1182/blood.V122.21.1888.1888
Published: 2013
Journal Articles

Safety Profile Of Bortezomib Impacts Survival Of Cardiac AL Amyloidosis

Zoé Van de Wyngaert, MD, Greg Vanoutryve, Charles Herbaux, MD, Guillemette Fouquet, MD, Helene Demarquette, MD, Sarah Bonnet, MD, David Beauvais, MD, Stéphanie Guidez, MD, Nicolas Lamblin, MD, Eric Hachulla, MD, PhD, David Launay, Louis Terriou, MD, Bénédicte Hivert, MD, Mathieu Wemeau, MD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5316.
https://doi.org/10.1182/blood.V122.21.5316.5316
Published: 2013
Journal Articles

Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenström macroglobulinemia

Clinical Trials & Observations
Benedicte Hivert, Claudine Caron, Stephanie Petit, Cecile Charpy, Corinne Fankam-Siaka, Stephanie Lecocq, Christophe Zawadzki, Sophie Susen, Manuela Rusu, Alain Duhamel, Olivier Tournilhac, Jenny Goudemand, Pierre Morel
Journal: Blood
Blood (2012) 120 (16): 3214–3221.
https://doi.org/10.1182/blood-2011-11-388256
Published: 2012
Includes: Supplemental data
Journal Articles

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients

Clinical Trials & Observations
Pierre Morel, Alain Duhamel, Benedicte Hivert, Laure Stalniekiewicz, Jean-Loup Demory, Brigitte Dupriez
Journal: Blood
Blood (2010) 115 (22): 4350–4355.
https://doi.org/10.1182/blood-2009-12-255943
Published: 2010
Includes: Supplemental data
Journal Articles

Prognostic Value of PINI in Elderly Patients with Multiple Myeloma (MM).

Sophie Dupire, Houria Debarri, Laurent Pascal, Valerie Coiteux, Benedicte Hivert, Christophe Willekens, Julien Rossignol, Ibrahim Yakoub-Agha, MD, PhD, Brigitte Onraed, Jean-Luc Faucompré, Bernadette Hennache, Charles Dumontet, Thierry Facon, Xavier Leleu
Journal: Blood
Blood (2009) 114 (22): 2493.
https://doi.org/10.1182/blood.V114.22.2493.2493
Published: 2009